NMI Holdings, Inc. NMIH 深 滬
已收盤 01-09 16:00:00 美东时间
40.48
0.000
0.00%
華盛通- 最 高41.00
- 今 開40.57
- 成交量 34.34万股
- 最 低 40.45
- 昨 收 40.48
- 總市值 31.12亿
- 52周最高 43.20
- 市盈率 靜 9.14
- 換手率 0.45%
- 52周最低 31.90
- 委 比 0.00%
- 總股本 7686.79万
- 歷史最高 43.20
- 量 比 0.98
- 振 幅 1.36%
- 歷史最低 4.19
- 每 手 1
- 風險率 2.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
Barclays Maintains Equal-Weight on NMI Holdings, Raises Price Target to $44
Barclays analyst Terry Ma maintains NMI Holdings (NASDAQ:NMIH) with a Equal-Weight and raises the price target from $43 to $44.
01-07 04:11
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
Keefe, Bruyette & Woods Upgrades NMI Holdings to Outperform, Raises Price Target to $48
Keefe, Bruyette & Woods analyst Bose George upgrades NMI Holdings (NASDAQ:NMIH) from Market Perform to Outperform and raises the price target from $46 to $48.
2025-12-18 17:22
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
2025-11-06 09:55
JP Morgan Maintains Overweight on NMI Holdings, Lowers Price Target to $42
JP Morgan analyst Richard Shane maintains NMI Holdings (NASDAQ:NMIH) with a Overweight and lowers the price target from $43 to $42.
2025-11-06 04:09
CORRECTION: NMI Holdings Q3 Adj. EPS $1.21, Inline, Sales $178.679M Beat $150.573M Estimate
NMI Holdings (NASDAQ:NMIH) reported quarterly earnings of $1.21 per share which met the analyst consensus estimate. This is a 5.22 percent increase over earnings of $1.15 per share from the same period last year. The
2025-11-05 06:58
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
2025-11-04 19:12
美股大行评级 | 潜在涨幅4347.41%！Ascendiant Capital上调PAVmed目标价至20美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从19美元升至20美元；Ascendiant Capital：维持Plus Therapeutics"买入"评级，目标价从20.5美元升至21美元
2025-10-07 15:04
Barclays Maintains Equal-Weight on NMI Holdings, Raises Price Target to $43
Barclays analyst Terry Ma maintains NMI Holdings (NASDAQ:NMIH) with a Equal-Weight and raises the price target from $42 to $43.
2025-10-06 21:20
